DE69107512T2 - Derivate von endogenen Mediatoren, ihre Salze, Verfahren zur Herstellung, Anwendungen und Zusammensetzungen, die diese enthalten. - Google Patents

Derivate von endogenen Mediatoren, ihre Salze, Verfahren zur Herstellung, Anwendungen und Zusammensetzungen, die diese enthalten.

Info

Publication number
DE69107512T2
DE69107512T2 DE69107512T DE69107512T DE69107512T2 DE 69107512 T2 DE69107512 T2 DE 69107512T2 DE 69107512 T DE69107512 T DE 69107512T DE 69107512 T DE69107512 T DE 69107512T DE 69107512 T2 DE69107512 T2 DE 69107512T2
Authority
DE
Germany
Prior art keywords
preparation
derivatives
applications
salts
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69107512T
Other languages
English (en)
Other versions
DE69107512D1 (de
Inventor
Jacques Chauveau
Michel Delaage
Anne Morel
Louis Segu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunotech SAS
Original Assignee
Immunotech SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9006292A external-priority patent/FR2662082B1/fr
Priority claimed from FR9101292A external-priority patent/FR2671971B1/fr
Application filed by Immunotech SAS filed Critical Immunotech SAS
Publication of DE69107512D1 publication Critical patent/DE69107512D1/de
Application granted granted Critical
Publication of DE69107512T2 publication Critical patent/DE69107512T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
DE69107512T 1990-05-15 1991-05-13 Derivate von endogenen Mediatoren, ihre Salze, Verfahren zur Herstellung, Anwendungen und Zusammensetzungen, die diese enthalten. Expired - Lifetime DE69107512T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9006292A FR2662082B1 (fr) 1990-05-15 1990-05-15 Nouveaux derives de mediateurs endogenes, leurs sels, procede de preparation et applications.
FR9101292A FR2671971B1 (fr) 1991-01-30 1991-01-30 Nouveaux derives de la serotonine, application a titre de medicament et compositions les renfermant.

Publications (2)

Publication Number Publication Date
DE69107512D1 DE69107512D1 (de) 1995-03-30
DE69107512T2 true DE69107512T2 (de) 1995-06-29

Family

ID=26228029

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69107512T Expired - Lifetime DE69107512T2 (de) 1990-05-15 1991-05-13 Derivate von endogenen Mediatoren, ihre Salze, Verfahren zur Herstellung, Anwendungen und Zusammensetzungen, die diese enthalten.

Country Status (12)

Country Link
US (1) US5298491A (de)
EP (1) EP0457701B1 (de)
JP (1) JP2968623B2 (de)
KR (1) KR0138750B1 (de)
AT (1) ATE118758T1 (de)
AU (1) AU650265B2 (de)
CA (1) CA2042295A1 (de)
DE (1) DE69107512T2 (de)
DK (1) DK0457701T3 (de)
ES (1) ES2039313T3 (de)
IE (1) IE67888B1 (de)
NO (1) NO308663B1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW288010B (de) * 1992-03-05 1996-10-11 Pfizer
JP2544704B2 (ja) * 1992-04-10 1996-10-16 フアイザー・インコーポレイテツド ５−ｈｔ▲下１▼アゴニストとしてのアシルアミノインド―ル誘導体
TW251284B (de) * 1992-11-02 1995-07-11 Pfizer
FR2699918B1 (fr) * 1992-12-30 1995-03-17 Pf Medicament Ligands sélectifs des récepteurs 5HY1D-5HT1B dérivés d'indole-pipérazine utiles comme médicaments.
NZ267453A (en) * 1993-06-18 1997-03-24 Nycomed Imaging As Substituted Factor vii derived peptides
AU729415B2 (en) 1996-07-12 2001-02-01 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
FR2773489B1 (fr) * 1998-01-15 2001-03-23 Immunotech Sa Nouvelle composition destinee a la voie oromuqueuse notamment pernasale
KR100596641B1 (ko) * 1998-12-11 2006-10-04 이승진 진단용 공중합성 미셀 및 그의 제조방법
US7163918B2 (en) * 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US20060014697A1 (en) * 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
DK1523486T3 (da) 2002-06-21 2008-03-03 Suven Life Sciences Ltd Tetracykliske arylsulfonylindoler med serotoninreceptor-affinitet
EP1537113B9 (de) 2002-06-21 2010-05-26 Suven Life Sciences Limited Sich als therapeutische mittel eignende arylalkylindole mit affinität für den serotoninrezeptor, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
KR100818508B1 (ko) 2002-11-28 2008-03-31 수벤 라이프 사이언시스 리미티드 세로토닌 수용체 친화력을 가지는 엔-아릴술포닐-3-치환인돌, 그 제조방법 및 그를 포함하는 약제학적 조성물
ES2425143T3 (es) 2002-11-28 2013-10-11 Suven Life Sciences Limited N-Arilsulfonil-3-aminoalcoxiindoles
KR100739987B1 (ko) 2002-12-18 2007-07-16 수벤 라이프 사이언시스 리미티드 세로토닌 수용체 친화력을 가지는 테트라사이클릭 3-치환인돌

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2703325A (en) * 1951-12-06 1955-03-01 Upjohn Co Preparation of 5-benzyloxytryptamines
US3182071A (en) * 1961-06-27 1965-05-04 Warner Lambert Pharmaceutical Acylated indole derivatives
US3686213A (en) * 1970-08-28 1972-08-22 American Cyanamid Co Substituted aminoethyl indoles
US4046636A (en) * 1974-06-20 1977-09-06 Syva Company Diazepam enzyme conjugates
US3878187A (en) * 1972-09-11 1975-04-15 Syva Co Polypeptide derivatives of amphetamine and analogs for immunoassays
US4040907A (en) * 1974-06-20 1977-08-09 Syva Company Iodothyronine enzyme conjugates
DE2737802A1 (de) * 1977-08-22 1979-03-08 Henning Berlin Gmbh Arzneimittel oder diagnostikum zur behandlung oder feststellung von schilddruesenfunktionsstoerungen und verfahren zu dessen herstellung
FR2437398A1 (fr) * 1978-06-20 1980-04-25 Commissariat Energie Atomique Compose iode utilisable comme traceur en radio-immunologie
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
US4426453A (en) * 1980-09-18 1984-01-17 Amersham International Limited Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds
DE3368258D1 (en) * 1982-07-16 1987-01-22 Beecham Group Plc 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them
JPS60132935A (ja) * 1983-12-20 1985-07-16 Sumitomo Chem Co Ltd フエニルセリン誘導体及びその製造方法
FR2562671B1 (fr) * 1984-04-10 1986-07-25 Immunotech Sa Procede pour le dosage immunologique des monoamines
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
DE3628795A1 (de) * 1986-08-25 1988-03-03 Hoechst Ag Neue thyroninderivate
US5019586A (en) * 1987-04-14 1991-05-28 Glaxo Group Limited Ketone derivatives
GB8801306D0 (en) * 1988-01-21 1988-02-17 Ici Plc Chemical compounds
GB8802127D0 (en) * 1988-02-01 1988-03-02 Glaxo Group Ltd Chemical compounds
US4933324A (en) * 1988-02-26 1990-06-12 Shashoua Victor E Fatty acid-neuroactive drug conjugate as a prodrug
FR2662082B1 (fr) * 1990-05-15 1994-12-23 Immunotech Sa Nouveaux derives de mediateurs endogenes, leurs sels, procede de preparation et applications.
FR2671971B1 (fr) * 1991-01-30 1994-01-28 Immunotech Nouveaux derives de la serotonine, application a titre de medicament et compositions les renfermant.

Also Published As

Publication number Publication date
US5298491A (en) 1994-03-29
DE69107512D1 (de) 1995-03-30
ES2039313T3 (es) 1995-04-16
AU650265B2 (en) 1994-06-16
DK0457701T3 (da) 1996-02-05
IE911649A1 (en) 1991-11-20
EP0457701A1 (de) 1991-11-21
KR910020034A (ko) 1991-12-19
IE67888B1 (en) 1996-05-01
JPH04288044A (ja) 1992-10-13
ATE118758T1 (de) 1995-03-15
NO308663B1 (no) 2000-10-09
AU7704591A (en) 1991-11-21
NO911880D0 (no) 1991-05-14
KR0138750B1 (ko) 1998-05-01
CA2042295A1 (fr) 1991-11-16
JP2968623B2 (ja) 1999-10-25
ES2039313T1 (es) 1993-10-01
NO911880L (no) 1991-11-18
EP0457701B1 (de) 1995-02-22

Similar Documents

Publication Publication Date Title
DE69107512D1 (de) Derivate von endogenen Mediatoren, ihre Salze, Verfahren zur Herstellung, Anwendungen und Zusammensetzungen, die diese enthalten.
ES2131207T3 (es) Derivados de amidas del acido valproico y 2-valproenoico y su uso como anticonvulsivos.
PT96324A (pt) Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem
MX9304756A (es) 9-[(glicilo substituido)amido]-6-desmetil-6-desoxitetraciclinas, metodo para su produccion y composiciones farmaceuticas que las contienen.
BR0010555A (pt) Inibidores de neuraminidases
DK130883D0 (da) Fremgangsmade til fremstilling af terapeutiske eller diagnostiske praeparater
PT80683B (de) Verfahren zur herstellung von neue n-(2-nitrophenyl)-2-amino-pyrimidin-derivate
ES2052166T3 (es) Derivados de 24-homo-vitamina-d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos.
AT384424B (de) Verfahren zur herstellung von neuen 3-hydroxy-2-oxo-pyrrolidinderivaten und ihren salzen
MX7992A (es) Pinturas o lubricantes que contienen inhibidores de corrosion fenolicos.
BR8900834A (pt) 1,2,4-triazinodionas substituidas e processo para sua preparacao;compostos intermediarios para as mesmas e processos para sua preparacao;composicoes contra protozoarios parasitarios;processo para o combate dos mesmos;e processo para preparacao de composicoes contra protozoarios parasitarios
ATE49957T1 (de) Adamantanamin-derivate, verfahren zur herstellung und diese enthaltende heilmittel.
BR8902882A (pt) Composicao e processo para repelir insetos e acaros e processos para a preparacao de composicoes
ES2098570T3 (es) Amidas de un acido 4-amino-2-ureido-pirimidina-5-carboxilico, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su utilizacion.
MX9400176A (es) Metodo y composicion para inhibir la corrosion de metales empleando acidos politartaricos.
KR890008156A (ko) 깅콜리드의 신규 알콜시 유도체, 그 제조 방법 및 이를 함유한 치료 조성물
ES436883A1 (es) Procedimiento de preparacion de nuevos derivados de alcano- lamina y de sus isomeros opticos.
PT90840A (pt) Processo para a preparcao de 3-aminosidnoniminas substituidas e de composicoes farmaceuticas que as contem
KR890701584A (ko) 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물
DE69809888T2 (de) Verfahren zur Herstellung von alpha-Aminoketonen
DE59408751D1 (de) Verfahren zur Herstellung von Fettsäureamiden und ihre Verwendung
BR9611789A (pt) Processo para a preparação de derivados de ácido metoximino-fenilglioxílico
ATE51000T1 (de) Verfahren zur herstellung von alphaaminoalkylphosphon- und von alphaaminoalkylphosphins|uren.
FR2655989B1 (fr) Nouveaux derives d'amino-acides substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE69019591D1 (de) Phospholipase-A2-Inhibitor, Verfahren zu seiner Herstellung und diesen enthaltende pharmazeutische oder veterinäre Zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition